Millennium Management’s Innate Pharma IPHA Stock Holding History

Millennium Management’s Portfolio IPHA Stock Details IPHA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$12.9K	Sell	10,064 -10,244	-50%	-$16.7K	﹤0.01%	5525
2025 Q4	$35.5K	Buy	+20,308	New	+$39.2K	﹤0.01%	5772
2025 Q3	–	Sell	-11,661	Closed	-$20.4K	–	6237
2025 Q2	$20.4K	Sell	11,661 -3,665	-24%	-$7.44K	﹤0.01%	5679
2025 Q1	$27.3K	Buy	+15,326	New	+$29.9K	﹤0.01%	5596
2024 Q2	–	Sell	-10,579	Closed	-$30.5K	–	6208
2024 Q1	$30.5K	Sell	10,579 -1,423	-12%	-$3.73K	﹤0.01%	5762
2023 Q4	$33.6K	Sell	12,002 -34,971	-74%	-$86.8K	﹤0.01%	5545
2023 Q3	$119K	Sell	46,973 -2,477	-5%	-$7.26K	﹤0.01%	5292
2023 Q2	$155K	Sell	49,450 -12,449	-20%	-$38.3K	﹤0.01%	5213
2023 Q1	$176K	Sell	61,899 -9,785	-14%	-$31.4K	﹤0.01%	5225
2022 Q4	$267K	Buy	71,684 +57,050	+390%	+$130K	﹤0.01%	5167
2022 Q3	$29K	Sell	14,634 -2,222	-13%	-$6K	﹤0.01%	6357
2022 Q2	$46K	Sell	16,856 -8,259	-33%	-$24K	﹤0.01%	6226
2022 Q1	$84K	Sell	25,115 -29,906	-54%	-$110K	﹤0.01%	6224
2021 Q4	$252K	Buy	55,021 +27,903	+103%	+$148K	﹤0.01%	5702
2021 Q3	$167K	Sell	27,118 -19,649	-42%	-$84.7K	﹤0.01%	6212
2021 Q2	$155K	Sell	46,767 -2,967	-6%	-$11.8K	﹤0.01%	6110
2021 Q1	$214K	Sell	49,734 -4,963	-9%	-$22.2K	﹤0.01%	5458
2020 Q4	$224K	Sell	54,697 -17,960	-25%	-$80K	﹤0.01%	4744
2020 Q3	$288	Hold	72,657	–	–	﹤0.01%	3868
2020 Q2	$530K	Hold	72,657	–	–	﹤0.01%	3369
2020 Q1	$485K	Sell	72,657 -1,585	-2%	-$10.7K	﹤0.01%	2896
2019 Q4	$477K	Buy	+74,242	New	+$456K	﹤0.01%	3411

Other funds holding IPHA

LPC

Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

CIAM

Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

Millennium Management's IPHA Position: Q1 2026 in Review

Millennium Management reduced its Innate Pharma (IPHA) stake by 50% in Q1 2026, selling an estimated $16.7K and leaving 10,064 shares worth $12.9K. The position accounts for ﹤0.01% of the portfolio, ranked #5525.

Millennium Management first reported a position in IPHA in Q4 2019 and has held it in 22 quarters since. The position peaked at $530K in Q2 2020. 9 funds tracked by Wall St. Rank hold IPHA as of Q1 2026.

Millennium Management held 10,064 shares of Innate Pharma worth $12.9K as of Q1 2026.
Millennium Management sold 10,244 Innate Pharma shares in Q1 2026, an estimated $16.7K.
Innate Pharma made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #5525 holding.
Millennium Management first reported a position in Innate Pharma in Q4 2019 and has held it in 22 quarters since.
Millennium Management's Innate Pharma position peaked at $530K in Q2 2020.
9 funds tracked by Wall St. Rank held Innate Pharma as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.